as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹146.75
Change
-3.17 (-2.11%)
Open
₹150.18
Prev. Close
₹149.92
Day High
₹150.25
Day Low
₹145.69
Volume Analysis
Traded
97,338
Delivered
40,693
Delivery %
41.81%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (4)
- •Low return on equity (-3.82%)
- •Promoter holding is falling
- •Below-average fundamentals quality score (31/100)
- •Low operating margin (-19.0%)
Opportunities (0)
No signal for this stock
Threats (1)
- •FII holding has been falling
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹153.99 | ₹152.12 | ₹149.43 | ₹147.56 | ₹144.87 | ₹143.0 | ₹140.31 |
| Fibonacci | ₹152.12 | ₹150.38 | ₹149.3 | ₹147.56 | ₹145.82 | ₹144.74 | ₹143.0 |
| Camarilla | ₹148.0 | ₹147.59 | ₹147.17 | ₹147.56 | ₹146.33 | ₹145.91 | ₹145.5 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-44.98%
1 Week
-2.2%
1 Month
+3.3%
3 Months
+2.72%
6 Months
-25.78%
1 Year
-52.84%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
DuPont ROE Breakdown
-3.4%
Net margin -5.65% × asset turnover 0.46x × equity multiplier 1.31x
Company Overview
Sector
Information Technology
Market Cap
₹796 Cr
ROE
-3.82%
Book Value
₹80.4
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 19 Nov 2026. Not investment advice.
TopFund Analysis
Quick Heal Tech Ltd scores weakly on TopFund's composite fundamentals check within the Information Technology sector, at 31/100. The strongest factor is Financial Strength (100/100), while Growth (0/100) is the weakest area to weigh before deciding. Notably: Low return on equity (-3.82%); promoter holding is falling. FII holding has been falling.
TopFund Score — Fundamentals Quality
31/100 — WeakData confidence: 75/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company is almost debt free.
- +Company's working capital requirements have reduced from 90.4 days to 58.6 days
- −Company has low interest coverage ratio.
- −The company has delivered a poor sales growth of -4.76% over past five years.
- −Company has a low return on equity of 0.67% over last 3 years.
- −Company has high debtors of 192 days.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Head of Seqrite Labs, Sangamesh S, resigned effective November 13, 2026.
Seqrite Labs Head Sangamesh S resigned effective November 13, 2026.
Allotment of 1,210 Equity Shares under ESOP Scheme 2021
Quick Heal released Q2 FY27 investor call transcript; revenue rose 44% QoQ to ₹65 crore, PAT ₹5.8 crore.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 78 | 82 | 80 | 70 | 73 | 71 | 65 | 57 | 84 | 72 | 49 | 45 | 65 |
| Expenses + | 67 | 70 | 70 | 68 | 70 | 74 | 74 | 67 | 74 | 71 | 78 | 63 | 63 |
| Operating Profit | 11 | 12 | 10 | 3 | 3 | -4 | -8 | -10 | 9 | 0 | -29 | -18 | 2 |
| OPM % | 14.0% | 14.18% | 12.55% | 3.68% | 4.18% | -5.34% | -13.02% | -17.0% | 11.05% | 0.63% | -60.17% | -39.05% | 3.54% |
| Other Income + | 6 | 4 | 7 | 5 | 5 | 5 | 6 | 6 | 4 | 9 | 4 | 14 | 8 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 4 | 4 | 4 | 6 |
| Profit before tax | 13 | 13 | 14 | 5 | 5 | -2 | -7 | -7 | 10 | 6 | -30 | -7 | 4 |
| Tax % | 3.8% | 19.71% | -3.62% | 16.22% | 18.15% | -104.76% | -50.53% | -21.29% | 23.05% | -14.96% | -32.79% | -27.87% | -33.95% |
| Net Profit + | 13 | 10 | 14 | 4 | 4 | 0 | -3 | -6 | 8 | 7 | -20 | -5 | 6 |
| EPS in Rs | 2 | 2 | 3 | 1 | 1 | 0 | -1 | -1 | 1 | 1 | -4 | -1 | 1 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| YoY Sales growth | -22 | 23 | 62 | 37 | -6 | -14 | -19 | -19 | 14 | 1 | -25 | -21 | -22 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 286 | 302 | 300 | 318 | 315 | 286 | 333 | 342 | 278 | 292 | 280 | 261 | 230 |
| Expenses + | 194 | 200 | 210 | 198 | 187 | 195 | 192 | 235 | 276 | 274 | 286 | 290 | 274 |
| Operating Profit | 92 | 102 | 90 | 120 | 128 | 92 | 141 | 107 | 2 | 18 | -7 | -29 | -44 |
| OPM % | 32.0% | 34.0% | 30.0% | 38.0% | 41.0% | 32.0% | 42.0% | 31.0% | 0.7% | 6.0% | -2.4% | -11.0% | -19.0% |
| Other Income + | 8 | 10 | 25 | 30 | 33 | 31 | 24 | 19 | 22 | 21 | 21 | 23 | 35 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 20 | 24 | 31 | 27 | 24 | 22 | 19 | 17 | 16 | 13 | 13 | 14 | 17 |
| Profit before tax | 80 | 88 | 84 | 123 | 137 | 101 | 146 | 109 | 8 | 26 | 1 | -21 | -27 |
| Tax % | 33.0% | 34.0% | 37.0% | 33.0% | 33.0% | 27.0% | 27.0% | 23.0% | 20.0% | 8.0% | -404.0% | -47.0% | — |
| Net Profit + | 54 | 58 | 53 | 83 | 92 | 74 | 107 | 83 | 6 | 24 | 5 | -11 | -13 |
| EPS in Rs | 9 | 8 | 8 | 12 | 13 | 12 | 17 | 14 | 1 | 5 | 1 | -2 | -2 |
| Dividend Payout % | 85.0% | 30.0% | 33.0% | 25.0% | 15.0% | 35.0% | 24.0% | 31.0% | 207.0% | 66.0% | 0.0% | 0.0% | — |
| Sales growth | 18 | 6 | -1 | 6 | -1 | -9 | 16 | 3 | -19 | 5 | -4 | -7 | -17 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 270 | 559 | 592 | 653 | 719 | 580 | 687 | 570 | 367 | 383 | 387 | 382 | 382 |
| Borrowings + | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30 |
| Other Liabilities + | 97 | 88 | 72 | 57 | 63 | 52 | 75 | 88 | 74 | 76 | 83 | 110 | 103 |
| Total Liabilities | 428 | 717 | 734 | 781 | 853 | 697 | 827 | 716 | 493 | 513 | 525 | 547 | 569 |
| Fixed Assets + | 111 | 142 | 185 | 173 | 165 | 158 | 146 | 137 | 124 | 117 | 119 | 122 | 149 |
| CWIP | 74 | 55 | 14 | 14 | 11 | 3 | 2 | 0 | 0 | 3 | 0 | 0 | 1 |
| Investments | 130 | 115 | 182 | 306 | 390 | 310 | 416 | 318 | 198 | 190 | 179 | 213 | 264 |
| Other Assets + | 113 | 405 | 353 | 287 | 288 | 225 | 263 | 261 | 171 | 203 | 226 | 212 | 155 |
| Total Assets | 428 | 717 | 734 | 781 | 853 | 697 | 827 | 716 | 493 | 513 | 525 | 547 | 569 |
| Equity Capital | 61 | 70 | 70 | 70 | 71 | 64 | 64 | 58 | 53 | 54 | 54 | 54 | 54 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 77 | 78 | 36 | 94 | 61 | 71 | 99 | 80 | 31 | 18 | -22 | 15 |
| Cash from Investing Activity + | -53 | -163 | -73 | -122 | -37 | 148 | -92 | 126 | 185 | 6 | 16 | -26 |
| Cash from Financing Activity + | -18 | 189 | -20 | -19 | -24 | -221 | 0 | -214 | -212 | 2 | -10 | 3 |
| Net Cash Flow | 7 | 104 | -57 | -47 | 1 | -3 | 6 | -9 | 4 | 26 | -17 | -8 |
| Free Cash Flow | 11 | 42 | 2 | 80 | 54 | 60 | 90 | 79 | 32 | 12 | -36 | 6 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 116 | 92 | 73 | 100 | 91 | 114 | 90 | 106 | 2,064 | 102 | 325 | -80 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 24.13% | 23.81% | 23.61% | 23.68% | 23.42% | 23.52% | 24.46% | 25.53% | 25.73% | 26.62% | 28.08% | 28.16% |
| Promoters | 72.76% | 72.48% | 72.44% | 72.08% | 71.92% | 71.82% | 71.79% | 71.63% | 71.54% | 71.5% | 71.48% | 71.46% |
| FII | 1.66% | 1.65% | 1.54% | 1.61% | 1.81% | 2.03% | 1.16% | 0.5% | 0.45% | 0.73% | 0.46% | 0.4% |
| DII | 1.44% | 2.06% | 2.41% | 2.62% | 2.84% | 2.63% | 2.58% | 2.33% | 2.29% | 1.16% | 0.0% | 0.0% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Information Technology — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Quick Heal Tech Ltd (this stock) | 796 | — | 1.83 | -3.82% |
| Srit India Limited | 812 | 17.3 | — | 30.2% |
| Excelsoft Technologies L | 847 | 17.8 | 1.42 | 9.85% |
| Onward Technologies Ltd. | 851 | 17.1 | 3.44 | 19.5% |
| TVS Electronics Ltd | 730 | 74.2 | 8.39 | 11.6% |
| Digitide Solutions Ltd | 911 | 360.0 | 1.08 | -0.74% |
| Xchanging Solutions Ltd | 667 | 11.2 | 1.61 | 15.8% |
Which Mutual Funds Hold Quick Heal Tech Ltd?
Frequently Asked Questions about Quick Heal Tech Ltd
Quick Heal Tech Ltd (QUICKHEAL) closed at ₹146.75 on NSE on 19 November 2026, down 3.17 (2.11%) from the previous close.
Quick Heal Tech Ltd trades on the NSE (National Stock Exchange of India) under the symbol QUICKHEAL.
Quick Heal Tech Ltd has a dividend yield of 0.0%.
Quick Heal Tech Ltd's 52-week high is ₹321.0 and its 52-week low is ₹125.0.
Quick Heal Tech Ltd has a market capitalisation of ₹796 crore.
Quick Heal Tech Ltd has a TopFund Quality Score of 31/100 (Weak), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Quick Heal Tech Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.